医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SCIEX Appoints Joe Fox as President

2021年04月01日 PM10:00
このエントリーをはてなブックマークに追加


 

FRAMINGHAM, Mass.

SCIEX, a global leader in life science analytical technologies, announced Joe Fox as President, effective April 1, 2021. Mr. Fox assumes the role from Inese Lowenstein, who led SCIEX for four years. Ms. Lowenstein has been appointed Senior Talent Advisor at Danaher, responsible for new President coaching, DBS immersion tool development and advising on a variety of diversity and inclusion initiatives.

As President, Ms. Lowenstein accelerated innovation, enhanced commercial execution, and strengthened the presence of SCIEX in the biopharma space. It is with relentless dedication to customers that SCIEX brings exciting innovations to market and continues to drive what is possible with mass spectrometry and capillary electrophoresis.

“It has been a true privilege to work along-side all the amazing associates we have at SCIEX. I am proud of what we have accomplished as a team, by maintaining a steadfast commitment to developing innovative solutions that enable our customers in their quest to protect human safety and wellness,” said Ms. Lowenstein. “With Joe and the entire leadership team at the helm, I am confident the future for SCIEX is bright.”

Mr. Fox and the SCIEX leadership team will build on the strong momentum the company has achieved over the past four years. He will focus on extending the company’s leadership in quantitative LC-MS, and oversee the launch of innovative technologies later this year.

“Thanks to Inese and the entire team we are in a privileged position throughout the organization. Our passion for customers will continue, as will our commitment to deepening and diversifying our portfolio to better serve their needs,” said Mr. Fox. “The Power of Precision is both our mission and promise to customers. We will continue to advance analytical life science capabilities, and deepen and diversify our portfolio to empower them.”

Mr. Fox joined SCIEX in 2011 and has demonstrated exceptional leadership and DBS management in each of his roles. Most recently, as Senior Vice President, Global Sales and Service, Mr. Fox led and inspired a global commercial workforce across the Americas, EMEAI and JAPAC. His passion for employee engagement and empowerment will continue as President of SCIEX.

“Our innovation and dedication to service is our foundation, which is only possible due to our team of dedicated associates,” added Mr. Fox. “We will continue to establish SCIEX as a destination for the industry’s best talent, and will renew investment to ensure this remains the case. The SCIEX journey is just beginning!”

About SCIEX

SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. We have been at the forefront of the field of mass spectrometry for 50 years. From the launch of the first ever commercially successful triple quadrupole in 1981, we have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.

Today, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. Our customers are able to quickly respond to environmental hazards, better understand biomarkers relevant to disease, improve patient care in the clinic, bring relevant drugs to market faster and keep food healthier and safer.

That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.

For more information, visit sciex.com.

Let’s connect: Twitter, LinkedIn, Facebook, and Instagram.

Advances in human wellness depend on the power of precise science.

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to https://sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.

Trademarks and/or registered trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries.

© 2021 DH Tech. Dev. Pte. Ltd. RUO-MKT-12-13105-A.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210401005087/en/

CONTACT

Lulu VanZandt

Manager, Brand, Public Relations and Social Media, SCIEX

lulu.vanzandt@sciex.com

M: +1 (508) 782-9484

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 亚马逊与美国国家安全委员会携手开展业界首创合作项目,以解决美国常见的工伤问题
  • Aragen Announce Multi-Year Partnership With FMC Corporation, Aims at Accelerating Agro-Chemical Pipeline
  • 片肺換気中の高酸素血症介在疾患の罹患率にORiを指針とする酸素需要評価が及ぼす影響についての新研究
  • セルトリオン、抗COVID-19モノクローナル抗体治療剤「Regdanvimab(CT-P59)」の グローバル第3相臨床試験結果を発表
  • 沃特世推出SELECT SERIES MRT多反射飞行时间质谱平台,树立高分辨质谱性能新标杆